The latest on menopausal hormone therapy and breast cancer

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Menopause is a normal life stage for women at around 51 years. Most women don’t need treatment for their symptoms, but around 13% of Australian women aged 50-69 take menopausal hormone therapy (sometimes called “hormone replacement therapy”).

This medication contains hormones that are normally low or absent after menopause, and reduces symptoms such as hot flushes and night sweats, which can be troublesome and persistent for some women.

But growing evidence over recent years has pointed to an increased risk of breast cancer associated with menopausal hormone therapy. This has already led some women to stop or avoid the treatment.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Frozen Shoulder – A Practical Guide to Assessment and Management

Dr Robert Hungerford

Dr Robert Hungerford

Implementing the Four Pillars of Heart Failure Management in GP

Prof Robert Norman

Prof Robert Norman

PCOS Update

Dr Clare Tiedeman

Dr Clare Tiedeman

Biologics in COPD – 20% of Your Patients Could Benefit

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof Martha Hickey

writer

Prof Martha Hickey

Professor of Obstetrics and Gynaecology, University of Melbourne

Prof Mark Jenkins

writer

Prof Mark Jenkins

Director of the Centre for Epidemiology and Biostatistics, University of Melbourne

Test your knowledge

Recent articles

Latest GP poll

To what extent do you attribute the current political climate to experiences of racial/ethnic discrimination?

A great extent

0%

A moderate extent

0%

Slightly

0%

Not at all

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.